DOSE Rapid Dose Therapeutics Corp.

0.0664USD0.0950 CAD · CNQ+5.56%Mkt Cap: 9.15M USDP/E: —

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system designed to rapidly release p…

Key Statistics

Company
Market Cap9.15M USD
Enterprise Value13.26M USD
Revenue (TTM)1.48M USD
Gross Profit953.19K USD
Net Income (TTM)-2.37M USD
Revenue/Share0.01 USD
Last Price0.0664 USD
Fiscal Year EndFeb 2026
MR QuarterAug 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA75339A1012
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-10.94
EV/Revenue8.95
P/S6.18
P/B-1.61
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
0.055914% of range0.1329
52W High0.1329 USD
52W Low0.0559 USD
Profitability
Gross Margin49.15%
Oper. Margin-88.50%
EBITDA Margin-81.82%
Profit Margin-122.22%
ROE47.24%
ROA-103.26%
ROIC—
ROCE—
Growth
Revenue Growth-67.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-189.08K USD
CapEx (TTM)629 USD
FCF Margin-5.45%
FCF Yield-0.88%
Net Debt4.10M USD
Net Debt/EBITDA-3.39
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.72
Current Ratio0.03
Quick Ratio0.01
Book Value/Sh-0.04 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateFeb 16, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.137.78M
Float116.86M
Insiders17.02%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short3.30K
Short (prev mo.)254
Technical
SMA 500.0714 (-7.0%)
SMA 2000.0748 (-11.2%)
Beta-0.92
S&P 52W Chg8.68%
Avg Vol (30d)35.94K
Avg Vol (10d)20.85K
Technical Indicators
RSI (14)47.7
MACD-0.0015
MACD Signal-0.0010
MACD Hist.-0.0004
BB Upper0.0776 USD
BB Middle0.0678 USD
BB Lower0.0581 USD
BB Width28.69%
ATR (14)0.0056 USD
Vol Ratio (20d)11.05x

About Rapid Dose Therapeutics (CNSX: DOSE)

›

Rapid Dose Therapeutics (CNSX: DOSE) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.0950 CAD on 20 November 2026, down 42.4% over 52 weeks. Its 52-week range is 0.0800 CAD to 0.1900 CAD: the price is 50.0% below the high and 18.7% above the low.

Its market capitalisation is 13.09M CAD.

Rapid Dose Therapeutics reports return on equity of 47.2%, an operating margin of -88.5% and revenue down 67.8% year over year.

Its debt exceeds its cash by 5.87M CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.